Sanofi (SNY) Net Margin (QoQ) (2009 - 2026)
Powered by 
Analysis
Sanofi (SNY) Net Margin (QoQ) (2009 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 642.46 Bn | 621.70 Bn | 17.26 Bn |
| 2 | AbbVie | 448.37 Bn | 441.80 Bn | 12.70 Bn |
| 3 | Merck | 357.95 Bn | 350.81 Bn | 12.21 Bn |
| 4 | Novartis Ag | 267.68 Bn | 259.99 Bn | 11.24 Bn |
| 5 | Pfizer | 156.52 Bn | 144.82 Bn | 10.94 Bn |
| 6 | Sanofi | 52.15 Bn | 44.77 Bn | 10.79 Bn |
| 7 | Revolution Medicines | 42.98 Bn | 42.98 Bn | - |
| 8 | Incyte | 24.75 Bn | 20.21 Bn | 1.57 Bn |
| 9 | United Therapeutics | 21.52 Bn | 18.86 Bn | 683.80 Mn |
| 10 | Neurocrine Biosciences | 15.82 Bn | 15.43 Bn | 935.80 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -1,240.00 |
| Mar 31, 2026 | -6,166.00 |
| Dec 31, 2025 | 5,037.00 |
| Sep 30, 2025 | -1,277.00 |
| Jun 30, 2025 | 2,051.00 |
| Mar 31, 2025 | 1,116.00 |
| Dec 31, 2024 | -1,540.00 |
| Sep 30, 2024 | 1,135.00 |
| Jun 30, 2024 | -88.00 |
| Mar 31, 2024 | 2,248.00 |
| Dec 31, 2023 | -3,090.00 |
| Sep 30, 2023 | 670.00 |
| Jun 30, 2023 | -512.00 |
| Mar 31, 2023 | 555.00 |
| Dec 31, 2022 | -266.00 |
| Sep 30, 2022 | 502.00 |
| Jun 30, 2022 | -915.00 |
| Mar 31, 2022 | 249.00 |
| Dec 31, 2021 | -387.00 |
| Sep 30, 2021 | 844.00 |